🌍 Para-Clinical · subject
Para-Clinical Pharmacology Syllabus
The Pharmacology syllabus for Para-Clinical in full: 8 chapters, 30 topics and 97 sub-topics, every one listed below, plus 51 Pharmacology flashcards with answers.
Pharmacology syllabus: all 8 chapters
Expand any chapter to see its topics and sub-topics.
-
General Pharmacology
5 topics- Introduction to Pharmacology
- Definition and Scope
- Branches of Pharmacology
- Sources of Drugs
- Pharmacokinetics
- Absorption
- Distribution
- Metabolism
- Excretion
- Pharmacodynamics
- Mechanism of Drug Action
- Dose-Response Relationship
- Therapeutic Index
- Drug Receptors
- Types of Receptors
- Receptor Theories
- Receptor Regulation
- Adverse Drug Reactions
- Types of Adverse Reactions
- Drug Toxicity
- Management of Adverse Reactions
- Introduction to Pharmacology
-
Autonomic Nervous System Pharmacology
2 topics- Cholinergic Drugs
- Cholinergic Agonists
- Cholinesterase Inhibitors
- Anticholinergic Drugs
- Adrenergic Drugs
- Adrenergic Agonists
- Adrenergic Antagonists
- Indirect-Acting Adrenergic Agents
- Cholinergic Drugs
-
Cardiovascular Pharmacology
4 topics- Antihypertensive Drugs
- Diuretics
- Beta-Blockers
- Calcium Channel Blockers
- ACE Inhibitors
- ARBs
- Antianginal Drugs
- Nitrates
- Beta-Blockers
- Calcium Channel Blockers
- Antiarrhythmic Drugs
- Classification of Antiarrhythmics
- Mechanism of Action
- Clinical Uses
- Drugs for Heart Failure
- Cardiac Glycosides
- Diuretics
- ACE Inhibitors
- Beta-Blockers
- Antihypertensive Drugs
-
Central Nervous System Pharmacology
5 topics- Anxiolytics and Hypnotics
- Benzodiazepines
- Barbiturates
- Non-Benzodiazepine Hypnotics
- Antidepressants
- SSRIs
- SNRIs
- Tricyclic Antidepressants
- MAO Inhibitors
- Antipsychotics
- Typical Antipsychotics
- Atypical Antipsychotics
- Antiepileptic Drugs
- Mechanism of Action
- Classification of Antiepileptics
- Clinical Uses
- Analgesics
- Opioid Analgesics
- Non-Opioid Analgesics
- Adjuvant Analgesics
- Anxiolytics and Hypnotics
-
Endocrine Pharmacology
4 topics- Drugs for Diabetes Mellitus
- Insulin
- Oral Hypoglycemic Agents
- Non-Insulin Injectable Agents
- Thyroid and Antithyroid Drugs
- Thyroid Hormones
- Antithyroid Drugs
- Corticosteroids
- Glucocorticoids
- Mineralocorticoids
- Clinical Uses and Adverse Effects
- Sex Hormones
- Estrogens
- Progestins
- Androgens
- Drugs for Diabetes Mellitus
-
Chemotherapy
4 topics- Antibacterial Drugs
- Penicillins
- Cephalosporins
- Macrolides
- Quinolones
- Aminoglycosides
- Antiviral Drugs
- Antiretrovirals
- Antiviral Agents for Herpesviruses
- Antiviral Agents for Influenza
- Antifungal Drugs
- Azoles
- Echinocandins
- Polyenes
- Anticancer Drugs
- Alkylating Agents
- Antimetabolites
- Natural Products
- Targeted Therapies
- Antibacterial Drugs
-
Respiratory Pharmacology
3 topics- Drugs for Asthma
- Beta-Agonists
- Corticosteroids
- Leukotriene Modifiers
- Drugs for COPD
- Bronchodilators
- Phosphodiesterase-4 Inhibitors
- Combination Therapies
- Antitussives and Expectorants
- Opioid Antitussives
- Non-Opioid Antitussives
- Expectorants
- Drugs for Asthma
-
Gastrointestinal Pharmacology
3 topics- Drugs for Peptic Ulcer Disease
- Proton Pump Inhibitors
- H2 Receptor Antagonists
- Antacids
- Antiemetic Drugs
- Serotonin Antagonists
- Dopamine Antagonists
- Antihistamines
- Laxatives and Antidiarrheal Drugs
- Bulk-Forming Laxatives
- Stimulant Laxatives
- Osmotic Laxatives
- Antidiarrheal Agents
- Drugs for Peptic Ulcer Disease
Para-Clinical Pharmacology flashcards — 51 questions with answers
Define pharmacology and distinguish its two main divisions, pharmacokinetics and pharmacodynamics.
Pharmacology is the study of the interaction of drugs with living systems. Pharmacokinetics is what the body does to the drug (absorption, distribution, metabolism, excretion), whereas pharmacodynamics is what the drug does to the body (mechanism of action and effects).
What is the difference between a drug's efficacy and its potency?
Efficacy is the maximal effect a drug can produce ($E_{max}$), reflecting intrinsic activity. Potency is the amount of drug needed to produce a given effect, quantified by $EC_{50}$; a lower $EC_{50}$ means higher potency. A more potent drug is not necessarily more efficacious.
Define the therapeutic index and give its formula.
The therapeutic index (TI) measures drug safety, defined as $$TI = \frac{TD_{50}}{ED_{50}}$$ (or $LD_{50}/ED_{50}$ in animals). A larger TI indicates a wider safety margin.
In pharmacokinetics, define bioavailability (F) and state its value for an intravenous drug.
Bioavailability (F) is the fraction of an administered dose that reaches the systemic circulation unchanged. For an IV drug, $F = 1$ (100%) by definition; oral bioavailability is reduced by incomplete absorption and first-pass metabolism.
Give the formula for the volume of distribution ($V_d$) and explain what a large value implies.
$$V_d = \frac{\text{Amount of drug in body}}{\text{Plasma drug concentration}}$$ A large $V_d$ implies extensive distribution into tissues (e.g., lipophilic or highly tissue-bound drugs), with relatively low plasma concentration.
What determines the rate of first-order elimination, and how does it differ from zero-order kinetics?
In first-order (linear) kinetics a constant fraction of drug is eliminated per unit time, so rate is proportional to concentration. In zero-order kinetics a constant amount is eliminated per unit time (saturated enzymes), e.g., ethanol, phenytoin, aspirin at high doses.
State the relationship between elimination half-life ($t_{1/2}$), volume of distribution, and clearance.
$$t_{1/2} = \frac{0.693 \times V_d}{CL}$$ Half-life increases with larger $V_d$ and decreases with higher clearance (CL).
Write the formula for maintenance dosing rate at steady state.
$$\text{Maintenance dose rate} = \frac{CL \times C_{ss}}{F}$$ where $CL$ is clearance, $C_{ss}$ is target steady-state concentration, and $F$ is bioavailability.
Write the loading dose formula and explain why a loading dose is used.
$$\text{Loading dose} = \frac{V_d \times C_{target}}{F}$$ A loading dose rapidly achieves the target plasma concentration without waiting the ~4-5 half-lives needed to reach steady state by maintenance dosing alone.
Compare Phase I and Phase II drug metabolism reactions.
Phase I reactions (oxidation, reduction, hydrolysis; mainly cytochrome P450) introduce or unmask a functional group, often yielding active/toxic metabolites. Phase II reactions are conjugations (glucuronidation, sulfation, acetylation, glutathione) that add polar groups to increase water solubility for excretion.
Distinguish an agonist, a competitive antagonist, and a non-competitive antagonist.
An agonist binds a receptor and produces an effect (full or partial). A competitive antagonist binds reversibly at the same site, shifting the agonist dose-response curve right (surmountable, $E_{max}$ unchanged). A non-competitive antagonist binds irreversibly or allosterically, lowering $E_{max}$ (insurmountable).
What is a partial agonist, and how does it behave in the presence of a full agonist?
A partial agonist binds the receptor but produces a submaximal response even at full occupancy (low intrinsic activity). In the presence of a full agonist it acts as a partial antagonist, reducing the full agonist's maximal effect.
Define an inverse agonist.
An inverse agonist binds a receptor that has constitutive (basal) activity and produces the opposite effect, stabilizing the inactive state and reducing baseline activity below normal—distinct from a neutral antagonist, which merely blocks.
List the four major receptor superfamilies by signal transduction mechanism and their approximate response times.
1) Ligand-gated ion channels (milliseconds, e.g., nicotinic ACh receptor); 2) G-protein-coupled receptors (seconds, e.g., adrenergic); 3) Enzyme-linked/kinase receptors (minutes, e.g., insulin receptor); 4) Intracellular nuclear receptors (hours, e.g., steroid receptors altering gene transcription).
Explain receptor up-regulation and down-regulation and give a clinical consequence of each.
Down-regulation is a decrease in receptor number/sensitivity after chronic agonist exposure, causing tolerance/tachyphylaxis. Up-regulation is an increase after chronic antagonism or denervation, causing rebound/supersensitivity (e.g., beta-blocker withdrawal tachycardia).
Classify adverse drug reactions into Type A and Type B, giving features of each.
Type A (Augmented) reactions are dose-dependent, predictable, related to the drug's pharmacology, common, and low mortality (e.g., bleeding from warfarin). Type B (Bizarre) reactions are dose-independent, unpredictable, not related to known pharmacology (immunologic/idiosyncratic), rare, but high mortality (e.g., anaphylaxis, Stevens-Johnson syndrome).
Name the four types of hypersensitivity reactions (Gell and Coombs) with a drug example of each.
Type I: IgE-mediated immediate anaphylaxis (penicillin). Type II: antibody-mediated cytotoxic (methyldopa-induced hemolytic anemia). Type III: immune-complex (serum sickness). Type IV: T-cell-mediated delayed (contact dermatitis, some drug rashes).
Where are the main cholinergic receptor subtypes located, and what G-protein/channel do they use?
Nicotinic receptors ($N_M$ at neuromuscular junction, $N_N$ at autonomic ganglia/CNS) are ligand-gated cation channels. Muscarinic receptors $M_1, M_3, M_5$ couple to $G_q$ (increase IP3/DAG), while $M_2, M_4$ couple to $G_i$ (decrease cAMP); $M_2$ predominates in the heart, $M_3$ in smooth muscle/glands.
Contrast the mechanisms of pilocarpine and neostigmine as cholinergic drugs.
Pilocarpine is a direct-acting muscarinic agonist that stimulates receptors directly (used in glaucoma, xerostomia). Neostigmine is an indirect-acting reversible acetylcholinesterase inhibitor that raises endogenous ACh (used in myasthenia gravis, reversal of non-depolarizing blockade).
Describe the treatment of organophosphate (irreversible anticholinesterase) poisoning.
Atropine blocks muscarinic effects (SLUDGE symptoms), and pralidoxime reactivates acetylcholinesterase if given before 'aging' of the enzyme. Supportive care and diazepam for seizures are also used. Atropine does not reverse nicotinic (muscle) effects.
Show the other 31 Pharmacology flashcards
For adrenergic receptors, summarize the main effects mediated by $\alpha_1$, $\alpha_2$, $\beta_1$, and $\beta_2$.
$\alpha_1$: vasoconstriction, mydriasis, increased smooth muscle tone ($G_q$). $\alpha_2$: presynaptic inhibition of NE release, decreased sympathetic outflow ($G_i$). $\beta_1$: increased heart rate/contractility, renin release ($G_s$). $\beta_2$: bronchodilation, vasodilation, uterine relaxation ($G_s$).
How does the blood pressure response to epinephrine change after alpha-blockade (epinephrine reversal)?
Normally epinephrine raises BP ($\alpha_1$ vasoconstriction dominates). After alpha-blockade, only $\beta_2$-mediated vasodilation remains, so epinephrine now lowers BP—this paradoxical fall is called epinephrine reversal.
Compare the receptor selectivity and clinical uses of phenylephrine, dobutamine, and isoproterenol.
Phenylephrine is a selective $\alpha_1$ agonist (pressor, nasal decongestant, mydriatic). Dobutamine is a predominantly $\beta_1$ agonist (inotrope in acute heart failure). Isoproterenol is a non-selective $\beta$ agonist ($\beta_1 + \beta_2$), used rarely for bradycardia/heart block.
List the major classes of antihypertensive drugs with one example each.
Diuretics (hydrochlorothiazide); ACE inhibitors (enalapril); ARBs (losartan); calcium channel blockers (amlodipine); beta-blockers (metoprolol); alpha-blockers (prazosin); central sympatholytics (clonidine, methyldopa); direct vasodilators (hydralazine); and direct renin inhibitors (aliskiren).
What is the mechanism of ACE inhibitors and their two characteristic adverse effects?
ACE inhibitors block conversion of angiotensin I to angiotensin II and reduce bradykinin breakdown, causing vasodilation and reduced aldosterone. Characteristic adverse effects are a dry cough (bradykinin) and angioedema; they can also cause hyperkalemia and are contraindicated in pregnancy.
Why is methyldopa the preferred antihypertensive in pregnancy, and what is its mechanism?
Methyldopa is a centrally acting agent converted to alpha-methylnorepinephrine, an $\alpha_2$ agonist that reduces central sympathetic outflow. It has a long safety record in pregnancy with no adverse fetal effects, making it a first-line choice for gestational hypertension.
Explain how organic nitrates relieve angina.
Nitrates are metabolized to nitric oxide (NO), which activates guanylate cyclase, raising cGMP and causing smooth muscle relaxation. The dominant effect is venodilation, reducing preload and myocardial oxygen demand; they also dilate coronary arteries. Nitroglycerin is used sublingually for acute attacks.
Why must a nitrate-free interval be maintained, and what drug interaction is dangerous with nitrates?
Continuous nitrate exposure causes tolerance (depletion of sulfhydryl groups), so a daily nitrate-free interval of 8-12 hours preserves efficacy. Combining nitrates with PDE-5 inhibitors (sildenafil) causes profound, potentially fatal hypotension and is contraindicated.
Compare the three classes of antianginal drugs by how they reduce myocardial oxygen demand.
Nitrates reduce preload (venodilation). Beta-blockers reduce heart rate, contractility, and BP, lowering demand and prolonging diastolic coronary perfusion. Calcium channel blockers reduce afterload (vasodilation) and, for non-dihydropyridines, heart rate and contractility.
State the Vaughan Williams classification of antiarrhythmic drugs with the target of each class.
Class I: sodium channel blockers (Ia quinidine, Ib lidocaine, Ic flecainide). Class II: beta-blockers. Class III: potassium channel blockers (amiodarone, sotalol). Class IV: non-dihydropyridine calcium channel blockers (verapamil, diltiazem). Adenosine and digoxin are unclassified.
Contrast Class Ib and Class Ic sodium channel blockers by their effect on the action potential and typical use.
Class Ib (lidocaine) has fast dissociation, shortens action potential duration, minimally affects QRS, and targets ventricular arrhythmias (especially ischemic). Class Ic (flecainide) has slow dissociation, markedly slows conduction (widens QRS), no change in APD, and is used for supraventricular arrhythmias but is proarrhythmic post-MI.
List the major organ toxicities associated with amiodarone.
Amiodarone can cause pulmonary fibrosis, thyroid dysfunction (both hypo- and hyperthyroidism due to iodine content), hepatotoxicity, corneal microdeposits, blue-gray skin discoloration, and photosensitivity. It requires baseline and periodic pulmonary, thyroid, and liver monitoring.
Which drug classes reduce mortality in chronic heart failure with reduced ejection fraction (HFrEF)?
ACE inhibitors/ARBs (or ARNI—sacubitril/valsartan), beta-blockers (carvedilol, metoprolol succinate, bisoprolol), mineralocorticoid receptor antagonists (spironolactone/eplerenone), and SGLT2 inhibitors reduce mortality. Diuretics and digoxin relieve symptoms but do not improve survival.
Describe the mechanism of action of digoxin in heart failure.
Digoxin inhibits the $\ce{Na+/K+}$-ATPase, raising intracellular $\ce{Na+}$, which reduces $\ce{Na+/Ca^2+}$ exchange and increases intracellular $\ce{Ca^2+}$, producing a positive inotropic effect. It also increases vagal tone, slowing AV conduction (rate control in atrial fibrillation).
What factors predispose to digoxin toxicity, and what are its features?
Hypokalemia (competes at the same ATPase site), hypomagnesemia, hypercalcemia, and renal impairment predispose to toxicity. Features include nausea/vomiting, visual disturbances (yellow-green halos), confusion, and arrhythmias. Severe toxicity is treated with digoxin-specific antibody fragments (Digibind).
Explain the mechanism of benzodiazepines versus barbiturates at the $GABA_A$ receptor.
Both enhance $GABA_A$ chloride channel activity. Benzodiazepines increase the frequency of channel opening (require GABA present), giving a ceiling effect and greater safety. Barbiturates increase the duration of opening and at high doses directly open the channel, causing fatal respiratory depression with a low safety margin.
What is the antidote for benzodiazepine overdose, and what is a risk of its use?
Flumazenil, a competitive $GABA_A$ benzodiazepine-site antagonist, reverses benzodiazepine sedation. Risk: it can precipitate seizures in benzodiazepine-dependent patients or in mixed overdoses (e.g., with tricyclic antidepressants).
Classify antidepressants into their main groups with an example and shared mechanism theme.
SSRIs (fluoxetine)—block serotonin reuptake; SNRIs (venlafaxine)—block serotonin and norepinephrine reuptake; TCAs (amitriptyline)—block both plus muscarinic/H1/alpha effects; MAOIs (phenelzine)—inhibit monoamine oxidase; atypical (bupropion, mirtazapine). All ultimately increase synaptic monoamine availability; onset of benefit takes 2-4 weeks.
What is serotonin syndrome and its classic triad?
Serotonin syndrome is excess serotonergic activity (e.g., SSRI plus MAOI, or SSRI plus tramadol). Classic triad: neuromuscular abnormalities (clonus, hyperreflexia, rigidity), autonomic instability (hyperthermia, tachycardia), and altered mental status. Management is drug withdrawal, supportive care, and cyproheptadine.
Why must tyramine-rich foods be avoided with MAO inhibitors?
MAO normally degrades dietary tyramine. With MAOIs, tyramine accumulates and enters adrenergic nerves, displacing large amounts of stored norepinephrine, causing a hypertensive crisis ('cheese reaction'). Aged cheeses, cured meats, and fermented foods must be avoided.
Contrast the receptor profile and side effects of typical versus atypical antipsychotics.
Typical antipsychotics (haloperidol, chlorpromazine) block $D_2$ receptors strongly, giving high extrapyramidal symptoms (EPS) and hyperprolactinemia. Atypicals (risperidone, olanzapine, clozapine) block $D_2$ plus $5-HT_{2A}$, causing fewer EPS but more metabolic effects (weight gain, diabetes, dyslipidemia).
List the extrapyramidal symptoms of antipsychotics in their typical order of onset.
Acute dystonia (hours to days), akathisia (days to weeks), parkinsonism (weeks to months), and tardive dyskinesia (months to years, often irreversible). Neuroleptic malignant syndrome (rigidity, hyperthermia, autonomic instability, elevated CK) is a separate, life-threatening reaction.
What unique benefit and unique risk are associated with clozapine?
Clozapine is uniquely effective for treatment-resistant schizophrenia and reduces suicidality. Its major risk is agranulocytosis, requiring regular white cell count monitoring; it also lowers the seizure threshold and can cause myocarditis.
Match these antiepileptic drugs to their principal mechanisms: phenytoin, valproate, ethosuximide, benzodiazepines.
Phenytoin blocks voltage-gated $\ce{Na+}$ channels (use-dependent). Valproate blocks $\ce{Na+}$ channels, enhances GABA, and blocks T-type $\ce{Ca^2+}$ channels (broad spectrum). Ethosuximide blocks T-type $\ce{Ca^2+}$ channels (absence seizures). Benzodiazepines enhance $GABA_A$ (status epilepticus).
Which antiepileptic is first-line for status epilepticus and which for absence seizures?
Status epilepticus: intravenous benzodiazepine (lorazepam or diazepam) first, followed by a longer-acting agent such as phenytoin/fosphenytoin or levetiracetam. Absence seizures: ethosuximide (or valproate if generalized tonic-clonic seizures coexist).
Why is phenytoin difficult to dose, and what is its kinetic hallmark?
Phenytoin exhibits zero-order (saturable) kinetics at therapeutic doses, so small dose increases can cause disproportionate rises in plasma concentration and toxicity (nystagmus, ataxia, gum hyperplasia). It also has a narrow therapeutic range and is a strong CYP450 inducer.
Differentiate the mechanisms of NSAIDs and opioids as analgesics.
NSAIDs inhibit cyclooxygenase (COX-1/COX-2), reducing prostaglandin synthesis and peripheral sensitization (anti-inflammatory, antipyretic). Opioids act as agonists at $\mu$, $\kappa$, and $\delta$ receptors (GPCRs), inhibiting ascending pain pathways and altering pain perception centrally.
Describe the classic triad of opioid overdose and its antidote.
The triad is CNS depression (coma), respiratory depression, and pinpoint (miotic) pupils. The antidote is naloxone, a competitive opioid receptor antagonist; because it is short-acting, repeated doses or infusion may be needed to prevent re-sedation.
Classify oral antidiabetic drugs by mechanism with an example of each key class.
Biguanides (metformin)—decrease hepatic gluconeogenesis, increase insulin sensitivity; sulfonylureas (glibenclamide)—close $\ce{K_{ATP}}$ channels to stimulate insulin release; thiazolidinediones (pioglitazone)—PPAR-$\gamma$ agonists improving sensitivity; DPP-4 inhibitors (sitagliptin) and GLP-1 agonists (liraglutide)—incretin pathway; SGLT2 inhibitors (empagliflozin)—increase urinary glucose excretion.
Why is metformin first-line for type 2 diabetes, and what is its most serious adverse effect?
Metformin is first-line because it lowers glucose without causing hypoglycemia or weight gain, and has cardiovascular benefit. Its most serious (rare) adverse effect is lactic acidosis, so it is avoided in significant renal impairment, hypoxia, or severe hepatic disease.
Compare the mechanisms of carbimazole/methimazole and propylthiouracil in hyperthyroidism, and name the drug preferred in first-trimester pregnancy and thyroid storm.
Both are thioamides that inhibit thyroid peroxidase, blocking iodination and coupling of thyroglobulin. Propylthiouracil additionally inhibits peripheral conversion of $T_4$ to $T_3$. Propylthiouracil is preferred in the first trimester of pregnancy (less teratogenic) and in thyroid storm; carbimazole/methimazole is preferred otherwise.
Same Pharmacology syllabus in other exams
The Pharmacology outline above is identical in this exam:
Para-Clinical Pharmacology FAQ
What is in the Para-Clinical Pharmacology syllabus?
Para-Clinical Pharmacology is split into 8 chapters: General Pharmacology, Autonomic Nervous System Pharmacology, Cardiovascular Pharmacology, Central Nervous System Pharmacology, Endocrine Pharmacology, Chemotherapy, Respiratory Pharmacology and Gastrointestinal Pharmacology. Together they contain 30 topics and 97 sub-topics.
How many chapters are in Para-Clinical Pharmacology?
8 chapters, containing 30 topics and 97 sub-topics. The largest chapter is General Pharmacology, with 5 topics.
Are there flashcards for Para-Clinical Pharmacology?
Yes — a 51-card Pharmacology deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.